Medicrea Announces NASS 2018 Presence And Highlights a Recently Published Study Validating Its Predictive Modelling Approach for AIS Patients
Biospace,
Sept. 26, 2018 21:36 UTC LYON, France
Sept. 26, 2018 21:36 UTC LYON, France
The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the…
The Medicrea Group (Euronext Growth Paris: FR0004178572 - ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the…
The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the…
LYON, France
LYON, France
LYON, France
LYON, France
LYON, Frankreich
Medicrea gibt seine Teilnahme an der Eurospine 2018 bekannt und verweist auf eine kürzlich veröffentlichte Studie zur…
LYON, Frankreich
LYON, France
LYON, France
Medicrea Announces Eurospine 2018 Presence and Highlights a Recently Published Study Validating Its Predictive Modelling…
The Medicrea Group (Euronext Growth Paris: FR0004178572 ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the…